4TT7 |
Crystal structure of human ALK with a covalent modification |
date |
|
authors | Badger, J., Sridhar, V., Chie-Leon, B., Nienaber, V.L., Hausheer, F.H. |
compound |
source |
symmetry | |
|
crystal cell |
length a |
length b |
length c |
angle alpha |
angle beta |
angle gamma |
|
|
|
|
|
|
|
method | X-Ray Diffraction | resolution | 2.10 |
ligand | COM, EDO
| enzyme |
|
Gene Ontology |
Chain | Function | Process | Component | A |
|
|
|
|
Primary reference | Novel covalent modification of human anaplastic lymphoma kinase (ALK) and potentiation of crizotinib-mediated inhibition of ALK activity by BNP7787., Parker AR, Petluru PN, Nienaber VL, Zhao M, Ayala PY, Badger J, Chie-Leon B, Sridhar V, Logan C, Kochat H, Hausheer FH, Onco Targets Ther. 2015 Feb 4;8:375-83. doi: 10.2147/OTT.S73690. eCollection, 2015. PMID:25678804 |